The IAM Strategy 300 focuses exclusively on patent practitioners and has firmly established itself as the definitive 'go-to' resource for those seeking world-class legal patent expertise.
“One of the best IP strategists in Canada” François Painchaud is a sophisticated and poised negotiator who handles complex, high-value IP transactions with a deft touch.
Called to the Quebec Bar in 1986, François Painchaud has been a partner at ROBIC LLP for more than 25 years. He specialises in business law applied to key technology sectors, and is frequently involved in the negotiation and drafting of complex transactions relating to technology transfers, licensing, joint ventures as well as in commercial and corporate law, including venture capital, the establishment of consortiums, and mergers and acquisitions.
He held the position of president of the Licensing Executives Society International (LESI) from 2018 to 2019, and the position of director until May 2020. He has also acted as counsel, corporate secretary, and was a member of the board from 2011 to 2022. He is also a past president of Licensing Executives Society (LES) USA & Canada and was a member of the board of directors from 2001 to 2010.
Recent prestigious recognition includes IAM Strategy 300 – The World’s Leading IP Strategists 2023; IAM Strategy 300 Global Leaders 2023, LES USA Canada 2022 – the Frank Barnes Mentor Award; The Best Lawyers in Canada 2023 – Information Technology, Intellectual Property and Technology Law; LEXPERT Special Edition 2023– Technology and Health Sciences, LEXPERT Special Edition 2021– Health Sciences, Biotechnology, Intellectual Property and Technology Transactions; LESI Biotechnology, Intellectual Property and Technology Transactions 2021 – the Peter K Hess Award of achievement; Martindale-Hubbell Peer Review Rating 2023 in the "Highest Level of Professional Excellence" and "High Professional Achievement" categories; IAM Patent 1000 – The World’s Leading Patent Professionals 2023; and The Best Lawyers – Lawyer of the Year 2019, Technology Law in Montreal (he was also recognised as Lawyer of the Year in 2018, 2015, and 2014).
Mr Painchaud serves on the board of directors or as corporate secretary of various private and public organisations operating in life sciences and other technology-related fields. Since April 2018, he has been a member of the board of directors of Searchlight Pharma Inc, a Canada-based specialty pharmaceutical company. He is the corporate secretary of the Québec Consortium for Drug Discovery (CQDM) and CATALIS. He is also a board member of few not-for-profit organisations, including the Cancer Research Society. Finally, he was director and secretary of Axcan Pharma Inc until it became a close corporation in what was the biggest life sciences buyout on the Canadian stock market at the time.